![Diederik Engbersen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Diederik Engbersen
Director Ejecutivo en CimCure BV .
Perfil
Diederik Engbersen currently works at CimCure BV, as Chief Executive Officer from 2020 and FABPulous BV, as Chief Technology Officer.
Cargos activos de Diederik Engbersen
Empresas | Cargo | Inicio |
---|---|---|
FABPulous BV
![]() FABPulous BV Medical SpecialtiesHealth Technology FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands. | Director Técnico/Científico/I+D | - |
CimCure BV
![]() CimCure BV Miscellaneous Commercial ServicesCommercial Services CimCure BV is a Dutch new generation company founded in 2015 as a spin-off of the VU University Medical Center. CimCure is based in Amsterdam, Netherlands. The company focuses on the design and development of a novel class of active cancer vaccines that target the tumor blood vessels common to most solid tumors. CimCure has discovered and patented multiple highly specific targets and a novel conjugate vaccine technology that can induce polyclonal antibody responses to targets specific to the tumor vasculature. The company aims to combine the proven efficacy of tumor angiogenesis inhibition with the advantages that a vaccine may provide. The company was founded in 2015 by Arjan W. Griffioen, and Diederik Engbersen has been the CEO of the company since 2020. | Director Ejecutivo | 01/01/2020 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
FABPulous BV
![]() FABPulous BV Medical SpecialtiesHealth Technology FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands. | Health Technology |
CimCure BV
![]() CimCure BV Miscellaneous Commercial ServicesCommercial Services CimCure BV is a Dutch new generation company founded in 2015 as a spin-off of the VU University Medical Center. CimCure is based in Amsterdam, Netherlands. The company focuses on the design and development of a novel class of active cancer vaccines that target the tumor blood vessels common to most solid tumors. CimCure has discovered and patented multiple highly specific targets and a novel conjugate vaccine technology that can induce polyclonal antibody responses to targets specific to the tumor vasculature. The company aims to combine the proven efficacy of tumor angiogenesis inhibition with the advantages that a vaccine may provide. The company was founded in 2015 by Arjan W. Griffioen, and Diederik Engbersen has been the CEO of the company since 2020. | Commercial Services |
- Bolsa de valores
- Insiders
- Diederik Engbersen